Cannabinoids to Treat Serious Neurological and Inflammatory Conditions
Related Articles
FSD Pharma adds David Urban to Board of Directors
November 14, 2018
admin
Newsmakers
Comments Off on FSD Pharma adds David Urban to Board of Directors
TORONTO—-FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company’s Board of Directors. Mr. Urban is an accomplished business and government […]
Medicine Man Technologies (OTC: MDCL) to Acquire an Additional Four Dispensaries from an Established Retailer – Largest Transaction in Company History
September 9, 2019
admin
Consumer, Newsmakers
Comments Off on Medicine Man Technologies (OTC: MDCL) to Acquire an Additional Four Dispensaries from an Established Retailer – Largest Transaction in Company History
– This group of four dispensaries is expected to have EBITDA margins of 35% in 2019 and will be among the most profitable retail locations in the Company’s portfolio, upon transaction closing- Company is now […]
Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits
January 24, 2019
admin
CEO Interview, Consumer, Spotlight Stocks
Comments Off on Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]